Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1 1

Status

Completed 3

Sponsor Class

OTHER 31INDUSTRY 7NETWORK 3NIH 2OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3

Conditions

Multiple Myeloma 45Precursor Cell Lymphoblastic Leukemia-Lymphoma 20Leukemia 19Lymphoma 15Burkitt Lymphoma 8Neoplasms, Plasma Cell 5Hodgkin Disease 5Recurrence 4Leukemia, Biphenotypic, Acute 4Immunoglobulin Light-chain Amyloidosis 4Waldenstrom Macroglobulinemia 3Lymphoma, Large B-Cell, Diffuse 3Lung Neoplasms 3Vomiting 2Prostatic Neoplasms 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Nausea 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Anaplastic 2Disease 2Carcinoma, Non-Small-Cell Lung 2Uterine Cervical Neoplasms 1Thrombocytopenia 1Stomach Neoplasms 1Smoldering Multiple Myeloma 1Seminoma 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Oligodendroglioma 1

Interventions

Cyclophosphamide 15Vincristine 13Prednisone 13Rituximab 12Doxorubicin 11Etoposide 10Radiotherapy 9Methotrexate 6Filgrastim 6Cytarabine 6Gemcitabine 5Cisplatin 5VAP-cyclo protocol 4Granulocyte Colony-Stimulating Factor 4ibritumomab tiuxetan 3Peripheral Blood Stem Cell Transplantation 3Methylprednisolone 3Leucovorin 3Immunohistochemistry 3Ifosfamide 3Gene Expression Profiling 3Dexamethasone 3pegfilgrastim 2merphos 2fludarabine 2axicabtagene ciloleucel 2Watchful Waiting 2Specimen Handling 2Mesna 2Magnetic Resonance Spectroscopy 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NETWORK × Lymphoma, Large B-Cell, Diffuse × Dexamethasone × Clear all
NCT01846390 2026-03-27

Romidepsin, Gemcitabine, Dexamethasone and Cisplatin in the Treatment of Peripheral T-Cell and Diffuse Large B-Cell Lymphoma

Canadian Cancer Trials Group

Phase 1 Completed
21 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Peripheral

NCT00078949 2023-08-23

Chemotherapy Before Autologous Stem Cell Transplantation +/- Rituximab in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma

Canadian Cancer Trials Group

Phase 3 Completed
849 enrolled 13 charts
Lymphoid

Burkitt Lymphoma, Immunoblastic Lymphadenopathy, Lymphoma, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic

NCT00014209 2020-04-09

Combination Chemotherapy in Hodgkin's Disease or Non-Hodgkin's Lymphoma Not Responding to Previous Treatment

Canadian Cancer Trials Group

Phase 2 Completed
77 enrolled
Lymphoid

Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡